Morgan Stanley has recently raised Gilead Sciences Inc (GILD) stock rating, as announced on January 10, 2025, according to Finviz. Earlier, on December 10, 2024, BofA Securities had resumed the stock ...

Situated in Foster City, California, Gilead Sciences, Inc. (GILD) is a top biopharmaceutical company specializing in the ...

Piper Sandler analyst Joseph Catanzaro maintained a Buy rating on Keros Therapeutics (KROS – Research Report) today and set a price target of ...

The sellers never planned on owning the 30.7-acre property in Lyme, but bought it after a boat deal fell through. Now it’s ...

In a report released yesterday, Jasper Hellweg from Argus Research maintained a Buy rating on Novo Nordisk (NVO – Research Report). The ...

Explore some of the best blue-chip ETFs to buy for investors who want to sleep well at night (SWAN) during their retirement ...

The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research ...

The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research ...

Salesforce stock won an upgrade to buy from TD Cowen, which pointed to momentum for its new artificial intelligence platform.

Gildan Activewear Inc. hit a new 52-week high, surpassing its previous peak of C$71.55, which the company reached on January 15th.

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.

2-Year U.S. Treasury Note Continuous Contract $102.813 0.008 0.01% 5-Year U.S. Treasury Note Continuous Contract $106.258-0.008-0.01% 10-Year U.S. Treasury Note Continuous Contract $108.625 0.016 ...